Please provide your email address to receive an email when new articles are posted on . More than 72% of patients were either somewhat or very satisfied with their treatment outcomes. Over 84% of ...
VALENCIA, Calif. and MELBOURNE, Australia, April 13, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and ...
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (AVHHL) (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results